Massage Technique for Pain, Anxiety and Delirium in SAH Patients

Not Applicable

Completed

• Conditions: Pain; Delirium; Anxiety; Subarachnoid Hemorrhage; Sleep
• Interventions: Other: Massage

• Registration Number: NCT01982656
• Lead Sponsor: Sara E. Hocker, M.D

Brief Summary

This research study seeks to explore the effects of massage techniques on pain and anxiety relief among patients with subarachnoid hemorrhages in the ICU setting in comparison to subarachnoid hemorrhagic patients using standard medical therapy. In addition, our aim is to decrease the overall medication use to treat pain and anxiety, and to determine the impact of massage on sleep duration, quality, and breathing. Our goal is to improve and promote comfort during the ICU stay as well as decrease the need for narcotic medication usage.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-10-16
• Study First Submitted QC: 2013-11-04
• Study First Posted: 2013-11-13
• Study Start: 2013-12
• Primary Completion: 2017-12-31
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-21
• Study Completion: 2018-02-22
• Last Update Posted: 2018-02-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Clinical diagnosis of aneurysmal subarachnoid hemorrhage

Exclusion Criteria

• Upper extremity deep vein thrombus
• Active alcohol or drug withdrawal

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Massage technique	Massage	In addition to standard medical care and pharmacologic interventions, massage technique for 20 minutes for 5 to 14 days while in the ICU will be provided to help alleviate pain and anxiety in the patient.
No intervention	Massage	Patients with an aneurysmal subarachnoid hemorrhage will receive standard medical care to include pharmacologic interventions prescribed by the primary physician and nonpharmacologic interventions provided by the bedside RN such as ice or heat to address their pain and anxiety needs.

Primary Outcome Measures

Name	Time	Method
Change in Pain Score	Baseline to 14 days	Over the course of the intervention period, the primary outcome of decrease in pain will be decreased as compared to the control group. This will be measured using the Pain Scale.

Secondary Outcome Measures

Name	Time	Method
Sleep quantity	5-14 days

Trial Locations

Locations (1)

Mayo Clinic in Rochester; 🇺🇸 Rochester, Minnesota, United States